Celera is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera, spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011.[2]
Celera sequenced the human genome at a fraction of the cost of the publicly funded Human Genome Project (HGP), using about $300 million of private funding versus approximately $3 billion of taxpayer dollars.[citation needed] However, a significant portion of the human genome had already been sequenced when Celera entered the field, and thus Celera did not incur any costs with obtaining the existing data, which was freely available to the public from GenBank. Celera's approach, which used shotgun sequencing, spurred the public HGP to accelerate its effort and shift its projected timetable from 2005 to 2003.[citation needed]
Critics of initial efforts by Celera Genomics to hold back data from sections of genome they sequenced for commercial exploitation felt that it would retard progress in science as a whole. These critics pointed to the open access policy for gene sequences from the publicly funded Human Genome Project. Later, the company changed their policy and made their sequences available for non-commercial use but set a maximum threshold for amount of sequence data that a researcher could download at any given time.[citation needed]
The rise and fall of Celera as an ambitious competitor of the Human Genome Project is the main subject of the book The Genome War by James Shreeve, who followed Venter around for two years in the process of writing the book. A view from the public effort's side is that of Nobel laureate Sir John Sulston in his book The Common Thread: A Story of Science, Politics, Ethics and the Human Genome. Anthropologist Paul Rabinow also based his 2005 book A Machine to Make a Future on Celera.
^Venter, JC; et al. (2001). "The sequence of the human genome". Science. 291 (5507): 1304–1351. Bibcode:2001Sci...291.1304V. doi:10.1126/science.1058040. PMID 11181995.
^Singer, Emily (2007-09-04). "Craig Venter's Genome". MIT Technology Review. Five years ago, Craig Venter let out a big secret. As president of Celera Genomics, Venter had led the race between his company and a government-funded project to decode the human genome. After leaving Celera in 2002, Venter announced that much of the genome that had been sequenced there was his own.
Venter discusses Celera's progress in deciphering the human genome sequence and its relationship to healthcare and to the federally funded Human Genome Project.
U.S. National Institutes of Health website for the Human Genome Research Institute
January 01, 1970
celera, corporation, celera, subsidiary, quest, diagnostics, which, focuses, genetic, sequencing, related, technologies, founded, 1998, business, unit, applera, spun, into, independent, company, 2008, finally, acquired, quest, diagnostics, 2011, company, types. Celera is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies It was founded in 1998 as a business unit of Applera spun off into an independent company in 2008 and finally acquired by Quest Diagnostics in 2011 2 Celera CorporationCompany typeSubsidiaryTraded asNasdaq CRAIndustryTechnologyFounded1998HeadquartersAlameda California United StatesKey peopleWilliam G Green Chairman Kathy P Ordonez President Craig Venter FounderProductsScientific amp Technical InstrumentsNumber of employees554 1 Websitewww celera com Contents 1 History 2 Genomes sequenced by Celera Genomics 3 References 4 External linksHistory editOriginally headquartered in Rockville Maryland relocated to Alameda California it was established in May 1998 by PE Corporation later renamed to Applera with Dr J Craig Venter from The Institute for Genomic Research TIGR as its first president While at TIGR Venter and Hamilton Smith led the first successful effort to sequence an entire organism s genome that of the Haemophilus influenzae bacterium Celera was formed for the purpose of generating and commercializing genomic information Its stock is a tracking stock of Applera along with the tracking stock of Applera s larger Applied Biosystems Group business unit Celera sequenced the human genome at a fraction of the cost of the publicly funded Human Genome Project HGP using about 300 million of private funding versus approximately 3 billion of taxpayer dollars citation needed However a significant portion of the human genome had already been sequenced when Celera entered the field and thus Celera did not incur any costs with obtaining the existing data which was freely available to the public from GenBank Celera s approach which used shotgun sequencing spurred the public HGP to accelerate its effort and shift its projected timetable from 2005 to 2003 citation needed Critics of initial efforts by Celera Genomics to hold back data from sections of genome they sequenced for commercial exploitation felt that it would retard progress in science as a whole These critics pointed to the open access policy for gene sequences from the publicly funded Human Genome Project Later the company changed their policy and made their sequences available for non commercial use but set a maximum threshold for amount of sequence data that a researcher could download at any given time citation needed The rise and fall of Celera as an ambitious competitor of the Human Genome Project is the main subject of the book The Genome War by James Shreeve who followed Venter around for two years in the process of writing the book A view from the public effort s side is that of Nobel laureate Sir John Sulston in his book The Common Thread A Story of Science Politics Ethics and the Human Genome Anthropologist Paul Rabinow also based his 2005 book A Machine to Make a Future on Celera Genomes sequenced by Celera Genomics editEukaryotes Drosophila melanogaster fruit fly Human 3 specifically mostly that of Craig Venter 4 Anopheles gambiae mosquito Mouse 5 References edit Company Profile for Celera Group CRA Archived from the original on 2011 11 16 Retrieved 2008 10 22 https www celera com celera pr 1305673632 Archived 2011 07 09 at the Wayback Machine Quest Diagnostics Successfully Completes Acquisition of Celera May 17 2011 Venter JC et al 2001 The sequence of the human genome Science 291 5507 1304 1351 Bibcode 2001Sci 291 1304V doi 10 1126 science 1058040 PMID 11181995 Singer Emily 2007 09 04 Craig Venter s Genome MIT Technology Review Five years ago Craig Venter let out a big secret As president of Celera Genomics Venter had led the race between his company and a government funded project to decode the human genome After leaving Celera in 2002 Venter announced that much of the genome that had been sequenced there was his own Newspaperarticle from Handelsblatt 2000 10 12External links editCompany website Prepared Statement of Craig Venter of Celera Venter discusses Celera s progress in deciphering the human genome sequence and its relationship to healthcare and to the federally funded Human Genome Project U S National Institutes of Health website for the Human Genome Research Institute Retrieved from https en wikipedia org w index php title Celera Corporation amp oldid 1211438320, wikipedia, wiki, book, books, library,
